You are here

Novartis to buy pharmaceutical group AAA for US$3.9b


NOVARTIS is buying French-based Advanced Accelerator Applications (AAA) for US$3.9 billion, giving the Swiss drugmaker a platform in radiopharmaceuticals and access to a new therapy for the kind of cancer that killed Steve Jobs.

The cash offer...

Market voices on: